Showing results (471-480 of 1,892) with videos related to
Sort By:
Pageof 190
Immunotherapy|July 20, 2010
HER-2/neu as a target for cancer vaccinesConstantin N Baxevanis, Ioannis F Voutsas, Angelos D Gritzapis, et al.Immunotherapy|July 20, 2010
Immunotherapy of chronic myeloid leukemia: present state and future prospectsVladimír VonkaImmunotherapy|July 20, 2010
Immunotherapy for prion diseases: opportunities and obstaclesLi Li, Scott Napper, Neil R CashmanImmunotherapy|July 20, 2010
Natural human immunoglobulins in cancer immunotherapyH Peter Vollmers, Stephanie BrändleinImmunotherapy|July 20, 2010
MAGE A3 antigen-specific cancer immunotherapeuticNir Peled, Ana B Oton, Fred R Hirsch, et al.Immunotherapy|July 20, 2010
Adjunct immunotherapy with Ag85 complex proteins based subunit vaccine in a murine model of Mycobacterium tuberculosis infectionPramod K Giri, Indu Verma, Gopal K KhullerImmunotherapy|July 20, 2010
Tumor-associated macrophages as targets for tumor immunotherapyAndreas Weigert, Divya Sekar, Bernhard BrüneImmunotherapy|July 20, 2010
Immunodepletive anti-alpha/beta-TCR antibody in transplantation of composite tissue allografts: Cleveland Clinic research experienceMaria Siemionow, Aleksandra KlimczakImmunotherapy|July 20, 2010
Immunodrugs: breaking B- but not T-cell tolerance with therapeutic anticytokine vaccinesAlexander Link, Martin F BachmannImmunotherapy|July 20, 2010
Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical studyLisbeth Barkholt, Evren Alici, Reka Conrad, et al.Pageof 190